JPWO2019239216A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019239216A5
JPWO2019239216A5 JP2020568967A JP2020568967A JPWO2019239216A5 JP WO2019239216 A5 JPWO2019239216 A5 JP WO2019239216A5 JP 2020568967 A JP2020568967 A JP 2020568967A JP 2020568967 A JP2020568967 A JP 2020568967A JP WO2019239216 A5 JPWO2019239216 A5 JP WO2019239216A5
Authority
JP
Japan
Prior art keywords
virus
cells
sample
preparation
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020568967A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526826A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/000811 external-priority patent/WO2019239216A2/fr
Publication of JP2021526826A publication Critical patent/JP2021526826A/ja
Publication of JPWO2019239216A5 publication Critical patent/JPWO2019239216A5/ja
Pending legal-status Critical Current

Links

JP2020568967A 2018-06-13 2019-06-12 ウイルス検出アッセイ Pending JP2021526826A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862684277P 2018-06-13 2018-06-13
US62/684,277 2018-06-13
PCT/IB2019/000811 WO2019239216A2 (fr) 2018-06-13 2019-06-12 Dosage de détection virale

Publications (2)

Publication Number Publication Date
JP2021526826A JP2021526826A (ja) 2021-10-11
JPWO2019239216A5 true JPWO2019239216A5 (fr) 2022-06-17

Family

ID=68842951

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020568967A Pending JP2021526826A (ja) 2018-06-13 2019-06-12 ウイルス検出アッセイ

Country Status (6)

Country Link
US (1) US20230151438A1 (fr)
EP (1) EP3807423A4 (fr)
JP (1) JP2021526826A (fr)
AU (1) AU2019286345A1 (fr)
CA (1) CA3103367A1 (fr)
WO (1) WO2019239216A2 (fr)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19709186C2 (de) * 1997-03-06 1999-10-14 Medigene Ag Filtrationsverfahren zur Trennung von Viren
CA2393844A1 (fr) * 1999-12-14 2001-06-21 Genovo, Inc. Methodes et compositions destinees a la fabrication d'adenovirus incompetents pour la replication
JP2008501360A (ja) * 2004-06-11 2008-01-24 カソリック ユニバーシティー インダストリー アカデミー コオペレーション ファウンデーション CEA−特異的な細胞毒性T細胞を生成する組み換えアデノウイルスAdVCEAで形質導入された樹枝状細胞、及びこれを含むワクチン並びに薬剤学的組成物
RU2573912C2 (ru) * 2008-10-08 2016-01-27 Интрексон Корпорейшн Сконструированные клетки, экспрессирующие множественные иммуномодуляторы, и их применения
WO2011028531A1 (fr) * 2009-08-24 2011-03-10 Baylor College Of Medicine Génération de lignées de ctl avec une spécificité à l'encontre de multiples antigènes tumoraux ou de multiples virus
AU2011204405B2 (en) * 2010-01-05 2015-06-18 Vascular Biogenics Ltd. Methods for use of a specific anti-angiogenic adenoviral agent
US10238734B2 (en) * 2010-03-23 2019-03-26 The Regents Of The University Of California Compositions and methods for self-adjuvanting vaccines against microbes and tumors
WO2012089240A1 (fr) * 2010-12-28 2012-07-05 Qiagen Hamburg Gmbh Sonde oligonucléotidique pour la détection d'un adénovirus
WO2013088114A1 (fr) * 2011-12-12 2013-06-20 Cell Medica Limited Procédé de propagation de cellules t
SI3016512T1 (sl) * 2013-07-05 2020-07-31 H. Lee Moffitt Cancer Center And Research Institute, Inc. Topni CD33 za zdravljenje mielodisplastičnih sindromov (MDS)
JP7136701B2 (ja) * 2016-05-25 2022-09-13 ザ カウンシル オブ ザ クイーンズランド インスティテュート オブ メディカル リサーチ 同種異系t細胞を用いた自己免疫疾患の処置方法

Similar Documents

Publication Publication Date Title
JP6816031B2 (ja) 非標準的なcd8+t細胞応答を生成するのに有用な方法および組成物
JP6971492B2 (ja) Hiv予備免疫化および免疫療法
Salvato et al. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence
KR102663972B1 (ko) 예비-면역화 단계가 없는 hiv 면역요법
Hamilton-Easton et al. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice
WO2020224395A1 (fr) Sonde, paire d'amorces, kit de pcr quantitative fluorescente et procédé de détection de lentivirus réplicatif
US20070196389A1 (en) Viral gene products and methods for vaccination to prevent viral associated diseases
JP2021511802A (ja) 複製可能ウイルスの存在または非存在を評価するための方法および試薬
WO2020224394A1 (fr) Sonde fluorescente, paire d'amorces, kit de pcr quantitative fluorescente et procédé de détection pour la détection de lentivirus
Sakaguchi et al. In vitro host range of feline morbillivirus
Mizuno et al. Crossreactivity of antibodies to canine CD25 and Foxp3 and identification of canine CD4+ CD25+ Foxp3+ cells in canine peripheral blood
US20220220175A1 (en) Novel cancer antigens and methods
Badenhoop et al. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
Ströhle et al. A new mumps virus lineage found in the 1995 mumps outbreak in western Switzerland identified by nucleotide sequence analysis of the SH gene
JP2021519069A (ja) 遺伝子改変リンパ球の製造方法
Eo et al. Plasmid DNA encoding CCR7 ligands compensate for dysfunctional CD8+ T cell responses by effects on dendritic cells
KR20220034040A (ko) 신규한 암 항원 및 방법
Romanutti et al. Virus isolation and full-length genome sequencing of a representative canine distemper virus wild type strain of the South America 2 clade
KR20210080372A (ko) 신규의 암 항원 및 방법
JPWO2019239216A5 (fr)
EP4395809A1 (fr) Vecteurs de hcmv recombinants et leurs utilisations
Ponniah et al. Selective response of gamma delta T-cell hybridomas to orthomyxovirus-infected cells
CN113248577B (zh) 一种以腺病毒为载体的冠状病毒疫苗及其制备方法
AKARI et al. Simian T cell leukemia virus type I-induced malignant adult T cell leukemia-like disease in a naturally infected African green monkey: implication of CD8+ T cell leukemia
US20230151438A1 (en) Viral detection assay